Using Modern Imaging Technology

Learn More

With new, proprietary drug formulations

Learn More

To precisely treat late stage and metastatic cancer

Learn More

and to stimulate a natural, adaptive immune response.

Learn More

Intensity Therapeutics is creating a new, highly effective cancer treatment - in situ vaccination.

Learn More

About Intensity Therapeutics


National Cancer Institute
Jay Berzofsky, MD, PhD - Center for Cancer Research NIH; Chief of the Vaccine Branch
Masaki Terabe, PhD - Center for Cancer Research NIH and National Cancer Institute

Claude Nicaise MD – is President of Clinical Regulatory Services.  Dr. Claude Nicaise served as Senior Vice President of Strategic Product Development and Global Regulatory Affairs, a position he held since joining the company in 2008. At Alexion, Dr. Nicaise responsibilities were for the company's regulatory activities worldwide.  Prior to joining Alexion, Dr. Nicaise worked for Bristol-Myers Squibb for 24 years, where he held numerous senior management roles, including Vice President of Global Development; Vice President of Worldwide Regulatory Science and Global Regulatory Strategy; Vice President of Worldwide Regulatory Science and Strategy for Oncology.


Chris J. Viau, PhD, DABT - is President of CJV Toxicology, LLC and a member of PharmaDirections, Inc.  Dr. Viau has twenty-nine years of applied technical, managerial and leadership expertise in toxicology, safety pharmacology, drug metabolism, pharmacokinetics, and product development across multiple therapeutic areas.  He previous has worked at Sunovion Pharmaceuticals (formerly Sepracor), and Hoechst-Marion Roussel (currently part of Sanofi-Aventis).

Robert Cooke - has over 25 years experience in the Medical Imaging field, having served in executive leadership positions at Agfa Healthcare and Fujifilm Medical Systems. Mr. Cooke is currently a Vice President at National Decision Support Company and an Entrepreneur.

Contact Us

Intensity Therapeutics, Inc.
61 Wilton Road, 3rd Floor
Westport, CT 06880

Tel. (203) 221-7377
Fax (203) 664-1051


Click here for career inquiries

Who we are

Intensity Therapeutics is a clinical development stage company.  We are seeking partnerships/investors interested in advancing the company’s anti-cancer platform technology and lead product INT230-6.


Click here for inquiries